Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study).

Takano H, Mizuma H, Kuwabara Y, Sato Y, Shindo S, Kotooka N, Fujimatsu D, Kobayashi Y, Inoue T, Node K, Komuro I; PEARL Study Investigators.

Circ J. 2013;77(4):917-25. Epub 2013 Mar 15.

2.

Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: the pitavastatin heart failure study (PEARL study).

Mizuma H, Inoue T, Takano H, Shindo S, Oka T, Fujimatsu D, Kuwabara Y, Node K, Komuro I; PEARL Study Investigators.

Int J Cardiol. 2012 Apr 19;156(2):144-7. doi: 10.1016/j.ijcard.2010.10.022. Epub 2010 Nov 13.

PMID:
21075465
3.

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.

Lee HY, Cho HJ, Kim HY, Jeon HK, Shin JH, Kang SM, Baek SH.

Korean J Intern Med. 2014 Nov;29(6):754-63. doi: 10.3904/kjim.2014.29.6.754. Epub 2014 Oct 31.

5.

Effects of pitavastatin in Japanese patients with chronic heart failure. Reply.

Takano H.

Circ J. 2013;77(8):2205. Epub 2013 Jun 12. No abstract available.

PMID:
23759658
6.

Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.

Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.

Cardiology. 2007;108(1):28-34. Epub 2006 Sep 8.

PMID:
16960445
7.

Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.

Liu G, Zheng XX, Xu YL, Lu J, Hui RT, Huang XH.

Heart Lung Circ. 2014 Oct;23(10):970-7. doi: 10.1016/j.hlc.2014.05.005. Epub 2014 May 28. Review.

PMID:
24954758
8.

Effects of statin therapy on the production of monocyte pro-inflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia.

Nakagomi A, Seino Y, Kohashi K, Kosugi M, Endoh Y, Kusama Y, Atarashi H, Mizuno K.

Circ J. 2012;76(9):2130-8. Epub 2012 Jun 13.

9.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9. doi: 10.1016/j.jacc.2009.06.041.

10.

Rosuvastatin in older patients with systolic heart failure.

Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group.

N Engl J Med. 2007 Nov 29;357(22):2248-61. Epub 2007 Nov 5.

11.

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K; Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees.

Circulation. 2004 Oct 26;110(17):2618-26. Epub 2004 Oct 18.

12.

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.

Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332. Epub 2011 Jan 7.

13.

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.

Am Heart J. 2007 Jun;153(6):1055.e1-8.

PMID:
17540209
14.

Comparison of preventive effect on cardiovascular events with different statins. -The CIRCLE study-.

Maruyama T, Takada M, Nishibori Y, Fujita K, Miki K, Masuda S, Horimatsu T, Hasuike T.

Circ J. 2011;75(8):1951-9. Epub 2011 Jun 15.

15.

Effects of pitavastin in Japanese patients with chronic heart failure.

D'Imperio H, Sanchis J, Núñez E, Núñez J.

Circ J. 2013;77(8):2204. Epub 2013 Jun 12. No abstract available.

PMID:
23759657
16.

Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.

Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S; MUCHA Investigators.

Am Heart J. 2004 Feb;147(2):324-30.

PMID:
14760332
17.

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators.

Circulation. 2006 Feb 7;113(5):671-8.

18.

Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).

Yamamoto K, Origasa H, Hori M; J-DHF Investigators.

Eur J Heart Fail. 2013 Jan;15(1):110-8. doi: 10.1093/eurjhf/hfs141. Epub 2012 Sep 14.

19.

Statin therapy in chronic heart failure: frog prince or bare frog?

Kihara Y.

Circ J. 2013;77(4):895-7. Epub 2013 Mar 15. No abstract available.

20.

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.

Lipinski MJ, Cauthen CA, Biondi-Zoccai GG, Abbate A, Vrtovec B, Khan BV, Vetrovec GW.

Am J Cardiol. 2009 Dec 15;104(12):1708-16. doi: 10.1016/j.amjcard.2009.07.055.

PMID:
19962481

Supplemental Content

Support Center